Open Access · CC BY 4.0
Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML)
eJHaem · 2026-04 · 7 (2)
DOI: 10.1002/jha2.70260 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 09.03.2026. Verfasst von Ke Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology University College London Hospitals NHS Foundation Trust London UK. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Haematology University College London Hospitals NHS Foundation Trust London UK.
- Specialist Integrated Haematology Malignancy Diagnostic Service Health Services Laboratories University College London Hospitals NHS Foundation Trust London UK.
- UCL School of Life and Medical Sciences University College London London UK.
Zitieren
APA
Xu, K., Boneva, T., & Nacheva, E. (2026). Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML). eJHaem, 7(2). https://doi.org/10.1002/jha2.70260
Vancouver
Xu K, Boneva T, Nacheva E. Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML). eJHaem. 2026;7(2). doi:10.1002/jha2.70260
BibTeX
@article{Xu2026,
author = {Xu, Ke and Boneva, Temenuzhka and Nacheva, Elisabeth},
title = {Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML)},
journal = {eJHaem},
year = {2026},
volume = {7},
number = {2},
doi = {10.1002/jha2.70260}
}
EUVIMED